Feed MYCOF
Summary
53 / 100 · Bulios Score
Valuation 6Growth -Profitability -Quality 79Debt 79Stability 50
What speaks for it
- It earns 50 CAD a year on every 100 CAD of invested capital.
- It holds more cash than debt: $809.3K against $371.8K.
What to watch
- You pay 36.7 CAD for 1 CAD of yearly profit, a lot for its sector.
- For every 100 CAD of bills due within a year it has 31 CAD of short-term assets.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveP/E today 36.7
Medical - Pharmaceuticals industry median
Today you pay 36.7 CAD for 1 CAD of yearly profit.
Valuation in detailIs it growing?
Revenue (CAD)
20122013201420262027
Diluted EPS (CAD)
20122013201420262027
- Analyst estimate
There is not enough revenue history yet to say how fast it grows.
Growth in detailDoes it make money?
Income figures for the last 12 months are not available.
Profitability in detailIs it financially healthy?
YesCash and short-term investments $809.3K
Debt $371.8K
Free cash flow over 12 months -$1.39M
Over the last 12 months it spent more cash than it brought in. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.